Mark Plavsic - Oct 16, 2024 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Technology Officer
Signature
/s/ Conor Kilroy, as Attorney-in-Fact
Stock symbol
AURA
Transactions as of
Oct 16, 2024
Transactions value $
-$72,723
Form type
4
Date filed
10/16/2024, 09:25 PM
Previous filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Sale -$72.7K -7.38K -5.74% $9.85 121K Oct 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney